hESC/hiPSC Lines
hESC LineOriginal Catalog
H1 WiCell
H7 WiCell
H9 WiCell
H13.b WiCell
H14 WiCell
WA25 WiCell
WA26 WiCell
There are some restrictions on research that may be conducted with human embryonic stem cells. Restrictions may differ between cell lines, and the cell line owners/providers are responsible for defining the restrictions specific to their cells. The restrictions are clearly identified in the MOU-SLA, MTA and/or additional documents that correspond to a specific cell line. You must obtain these documents from the original owner prior to publication of any research using cell lines we can provide.
hiPSCOrigin of LineOrigin Cell TypeStatusCitation
Sev6 MRC-5; ATCC (CCL-171) Fibroblasts Apparently Healthy
MRC5.1 MRC-5; ATCC (CCL-171) Fibroblasts Apparently Healthy
706 Coriell (GM01706) Fibroblasts Apparently Healthy
036 Coriell (GM02036) Fibroblasts Apparently Healthy
153 Coriell (GM02153) Fibroblasts Apparently Healthy
204 Coriell (GM04204) Fibroblasts Apparently Healthy
652 Coriell (GM01652) Fibroblasts Apparently Healthy
680 Coriell (GM01680) Fibroblasts Apparently Healthy
864 Coriell (GM01864) Fibroblasts Apparently Healthy
731 Coriell (GM00731) Fibroblasts Apparently Healthy
879 Coriell (GM05879) Fibroblasts Apparently Healthy
369 Coriell (ND10504) B-Lymphocyte Parkinson's Disease (PARK2)
756 Coriell (ND14143) B-Lymphocyte Parkinson's Disease (GBA)
960 Coriell (ND16680) B-Lymphocyte Parkinson's Disease (Unspecified)
995 Coriell (ND13905) B-Lymphocyte Parkinson's Disease (LRRK2 G2019S)
972 Coriell (AG01972) Fibroblasts Hutchinson-Gilford Progeria Syndrome (LMNA)
There are some restrictions on research that may be conducted with human induced pluripotent stem cells. Restrictions may differ between cell lines, and the cell line owners/providers are responsible for defining the restrictions specific to their cells. The restrictions are clearly identified in the MOU-SLA, MTA and/or additional documents that correspond to a specific cell line. You must obtain these documents from the original owner prior to publication of any research using cell lines we can provide.